May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
A New Heavier–Than–Water Silicone Oil (HWS 46–300) as Prolonged Internal Tamponade Agent in Complicated Vitreo–Retinal Surgery: A Pilot Study
Author Affiliations & Notes
  • F. Genovesi–Ebert
    Ophthalmology, Eye, Pisa, Italy
  • V. Andrea
    Ophthalmology, Eye, Pisa, Italy
  • F. Cresti
    Ophthalmology, Eye, Pisa, Italy
  • E. Di Bartolo
    Ophthalmology, Eye, Pisa, Italy
  • S. Miniaci
    Ophthalmology, Eye, Pisa, Italy
  • M. Palla
    Ophthalmology, Eye, Pisa, Italy
  • C. Belting
    Ophthalmology, Eye, Pisa, Italy
  • S. Rizzo
    Ophthalmology, Eye, Pisa, Italy
  • Footnotes
    Commercial Relationships  F. Genovesi–Ebert, None; V. Andrea, None; F. Cresti, None; E. Di Bartolo, None; S. Miniaci, None; M. Palla, None; C. Belting, None; S. Rizzo, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4218. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. Genovesi–Ebert, V. Andrea, F. Cresti, E. Di Bartolo, S. Miniaci, M. Palla, C. Belting, S. Rizzo; A New Heavier–Than–Water Silicone Oil (HWS 46–300) as Prolonged Internal Tamponade Agent in Complicated Vitreo–Retinal Surgery: A Pilot Study . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4218.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : to report an interventional non–comparative pilot study using HWS 46–300, a new–generation mixture of ultra–purified silicone oil and F4H6,a semifluorinated alkane, as heavier–than–water tamponade

Methods: : 32 consecutive patients were recruited.The mean age was 59 years (range 20–83 years).At baseline 6 patients were aphakic,10 phakic and 16 pseudophakic .The indications included recurrent retinal detachment (RD)with PVR (stage ≥C2) arising from inferior or posterior tears and penetrating trauma. The patients underwent a pars plana vitrectomy, membrane peeling, and HWS 46–300 was used as long–term internal tamponade and removed 45 to96 days after the initial surgery. Baseline examination consisted in slit–lamp biomicroscopy, Goldman applanation tonometry, and direct and indirect ophthalmoscopy. Best–corrected visual acuity (BCVA) obtained and converted into logMAR was reported at entrance examination and at the last follow–up visit. Mean follow–up was 6 months after endotamponade removal. Main outcome was the anatomical reattachment of the retina in the absence of any tamponade agent, secondary goal was functional outcome and complications

Results: : At 1 months follow–up after the tamponade removal 27 eyes showed retinal re–attachment (84.4%).4 eyes showed recurrent RD and underwent p.p.vitrectomy and silicone oil 5000 cstks endotamponade. At 6 months follow–up after the HWS 46–3000 removal the retina was attached in the 27 eyes exchanged with BSS,and in the 5 eyes exchanged with silicone oil 5000 csks, endotamponade removal was successfully carried out.VA improved from logMAR +2,3 at baseline to logMAR +1,1 at 6 months (range +3 –0).7 eyes showed cataract formation (5 underwent phacoemulsification with IOL implant at the time of tamponade removal, and 2 were operated on at 6 months follow–up). With HWS 46–3000 in situ membranes formation was observed in 3 eyes, and uncontrolled raised intraocular IOP occurred in 1 eye: the tamponade removal controlled the IOP. Dispersion or emulsification was not observed. No patients showed intraocular inflammation with the endotamponade in situ

Conclusions: : Anatomic and functional results results are encourageing. Cataract formation occurred in 70% and was the most severe complication, membrane formations occurred only in 10 %.Our data suggest that HWS 46–3000 might be a useful tool in the treatment of RD complicated by inferior or posterior retinal breaks and PVR. Further study comparing this new tamponade agent to standard silicone oil will be necessary to assess its effectiveness

Keywords: retina • vitreoretinal surgery • vitreous substitutes 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.